Qiang Qiu

State Key Laboratory Of Biotherapy And Cancer Center
Chengdu, 610041, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications

Epigenetic Alterations in Hepatocellular Carcinoma: Mechanisms and Biomarkers for Precision Therapy.

Epigenetic Alterations in Hepatocellular Carcinoma: Mechanisms and Biomarkers for Precision Therapy.

Journal: Cancers
Published: June 01, 2026

Cholesterol sulfate replenishment rejuvenates aged hematopoietic stem cell phenomes.

Cholesterol sulfate replenishment rejuvenates aged hematopoietic stem cell phenomes.

Journal: Theranostics
Published: September 30, 2025

Rora Regulates Hematopoietic Stem Cell Phenotypes and Progression of Chronic Myelogenous Leukemia.

Rora Regulates Hematopoietic Stem Cell Phenotypes and Progression of Chronic Myelogenous Leukemia.

Journal: The American journal of pathology
Published: July 15, 2025

Exploring the potential toxic mechanisms of bisphenol F exposure in acute myeloid leukemia: Insights from network toxicology, molecular docking and experimental validation.

Exploring the potential toxic mechanisms of bisphenol F exposure in acute myeloid leukemia: Insights from network toxicology, molecular docking and experimental validation.

Journal: International immunopharmacology
Published: May 19, 2025

P-selectin overexpression impairs hematopoietic stem cell homeostasis via inflammatory receptor-mediated proliferation and differentiation.

P-selectin overexpression impairs hematopoietic stem cell homeostasis via inflammatory receptor-mediated proliferation and differentiation.

Journal: Cell death & disease
Published: May 09, 2025

A blockade of leukotriene-mediated Alox5 function provides a new strategy for the treatment of JAK2V617F-induced polycythemia vera.

A blockade of leukotriene-mediated Alox5 function provides a new strategy for the treatment of JAK2V617F-induced polycythemia vera.

Journal: Haematologica
Published: December 13, 2024

E3 Ubiquitin Ligases: Structures, Biological Functions, Diseases, and Therapy.

E3 Ubiquitin Ligases: Structures, Biological Functions, Diseases, and Therapy.

Journal: MedComm
Published: October 31, 2024

Preclinical and first-in-human of purinostat mesylate, a novel selective HDAC I/IIb inhibitor, in relapsed/refractory multiple myeloma and lymphoma.

Preclinical and first-in-human of purinostat mesylate, a novel selective HDAC I/IIb inhibitor, in relapsed/refractory multiple myeloma and lymphoma.

Journal: Signal transduction and targeted therapy
Published: October 02, 2024

Discovery of a Potent, Orally Active, and Long-Lasting P2X7 Receptor Antagonist as a Preclinical Candidate for Delaying the Progression of Chronic Kidney Disease.

Discovery of a Potent, Orally Active, and Long-Lasting P2X7 Receptor Antagonist as a Preclinical Candidate for Delaying the Progression of Chronic Kidney Disease.

Journal: Journal of medicinal chemistry
Published: September 23, 2024

Toxicokinetics, in vivo metabolic profiling and tissue distribution of chlorfenapyr in mice.

Toxicokinetics, in vivo metabolic profiling and tissue distribution of chlorfenapyr in mice.

Journal: Archives of toxicology
Published: July 17, 2024

Exploring the Health Benefits of Boletus aereus Polysaccharides: Extraction, Structural Characterization, and Antiproliferative Properties against Non-Hodgkin's Lymphomas (NHLs).

Exploring the Health Benefits of Boletus aereus Polysaccharides: Extraction, Structural Characterization, and Antiproliferative Properties against Non-Hodgkin's Lymphomas (NHLs).

Journal: Journal of agricultural and food chemistry
Published: July 12, 2024

Atp8a1 deletion increases the proliferative activity of hematopoietic stem cells by impairing PTEN function.

Atp8a1 deletion increases the proliferative activity of hematopoietic stem cells by impairing PTEN function.

Journal: Cellular oncology (Dordrecht, Netherlands)
Published: March 05, 2023
Showing 1-12 of 32

Last Updated: 09/26/2026